Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 2,018,755 | 1,508,934 | 1,020,282 | 496,749 | 1,877,483 |
| Accounts payable and accrued liabilities | -1,639,848 | -1,249,674 | -842,830 | -436,430 | -1,536,935 |
| Other Working Capital | 253,298 | 175,145 | 125,447 | 21,021 | 228,837 |
| Other Operating Activity | -369,470 | -253,166 | -172,818 | -61,558 | -343,476 |
| Operating Cash Flow | $262,735 | $181,239 | $130,081 | $19,782 | $225,909 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -124,704 | -134,115 | -99,732 | -48,214 | -32,650 |
| PPE Investments | -102,654 | -67,056 | -42,443 | -17,786 | -87,263 |
| Net Acquisitions | -158,538 | -8,698 | -5,228 | -3,571 | -89,307 |
| Purchase Sale Intangibles | -436 | -439 | -143 | -103 | -4,081 |
| Other Investing Activity | -436 | -4,020 | -10,673 | -7,722 | -7,292 |
| Investing Cash Flow | $-386,332 | $-213,889 | $-158,076 | $-77,293 | $-216,512 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 424,633 |
| Debt Repayment | -226,835 | -226,615 | -226,368 | -225,763 | -206,706 |
| Common Stock Issued | 14,249 | 13,031 | 10,458 | 7,638 | 12,730 |
| Other Financing Activity | -974 | 1,757 | 2,027 | 3,382 | -1,912 |
| Financing Cash Flow | $-213,560 | $-211,827 | $-213,883 | $-214,743 | $228,745 |
| Exchange Rate Effect | 4,837 | 8,954 | 5,628 | -6,389 | 18,471 |
| Beginning Cash Position | 906,551 | 906,551 | 906,551 | 906,551 | 649,938 |
| End Cash Position | 574,231 | 671,028 | 670,301 | 627,908 | 906,551 |
| Net Cash Flow | $-332,320 | $-235,523 | $-236,250 | $-278,643 | $256,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | 262,735 | 181,239 | 130,081 | 19,782 | 225,909 |
| Capital Expenditure | -102,888 | -67,233 | -42,557 | -17,809 | -88,453 |
| Free Cash Flow | 159,847 | 114,006 | 87,524 | 1,973 | 137,456 |